FDA-Approved Growth Factor
The first and only FDA-approved topical growth factor for diabetic foot ulcers. Regranex stimulates wound healing by promoting cell proliferation and new tissue formation.
Regranex (becaplermin) is a recombinant human platelet-derived growth factor (PDGF-BB) gel approved by the FDA specifically for lower extremity diabetic neuropathic ulcers that extend into subcutaneous tissue or beyond.
PDGF is one of the body's natural wound healing signals. It stimulates fibroblast proliferation, angiogenesis (new blood vessel formation), and granulation tissue development—all critical for wound closure.
First topical growth factor approved for diabetic foot ulcers
Clinical studies show 30-50% improvement in healing rates
Reimbursed under Medicare Part B for qualifying ulcers
25+ Years of Use
Trusted since 1997
Stimulates fibroblast division and migration
Promotes new blood vessel formation
Accelerates formation of healthy wound bed
Promotes wound edges to contract and close
Debride and remove necrotic tissue, rinse with saline
Measured amount spread evenly over wound surface
Moist saline gauze covered with secondary dressing
Applied once daily for up to 20 weeks or until healed
Our specialists will evaluate if you're a candidate for growth factor therapy
Schedule Evaluation